JP2005530723A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530723A5
JP2005530723A5 JP2003582175A JP2003582175A JP2005530723A5 JP 2005530723 A5 JP2005530723 A5 JP 2005530723A5 JP 2003582175 A JP2003582175 A JP 2003582175A JP 2003582175 A JP2003582175 A JP 2003582175A JP 2005530723 A5 JP2005530723 A5 JP 2005530723A5
Authority
JP
Japan
Prior art keywords
peptide
amino acids
ifnα
cytokine
derivative according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003582175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530723A (ja
Filing date
Publication date
Priority claimed from FR0204464A external-priority patent/FR2838444B1/fr
Application filed filed Critical
Publication of JP2005530723A publication Critical patent/JP2005530723A/ja
Publication of JP2005530723A5 publication Critical patent/JP2005530723A5/ja
Pending legal-status Critical Current

Links

JP2003582175A 2002-04-10 2003-04-09 新規ペプチド及び治療を目的とするその利用 Pending JP2005530723A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204464A FR2838444B1 (fr) 2002-04-10 2002-04-10 Nouveaux peptides et leur application en therapeutique
PCT/FR2003/001120 WO2003084979A2 (fr) 2002-04-10 2003-04-09 Peptides et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JP2005530723A JP2005530723A (ja) 2005-10-13
JP2005530723A5 true JP2005530723A5 (https=) 2006-05-25

Family

ID=28459716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003582175A Pending JP2005530723A (ja) 2002-04-10 2003-04-09 新規ペプチド及び治療を目的とするその利用

Country Status (20)

Country Link
US (6) US7393523B2 (https=)
EP (3) EP2314311B1 (https=)
JP (1) JP2005530723A (https=)
KR (1) KR101101004B1 (https=)
CN (1) CN1649898A (https=)
AT (1) ATE526985T1 (https=)
AU (1) AU2003260031B2 (https=)
CA (1) CA2480996C (https=)
DK (1) DK2314311T3 (https=)
ES (2) ES2550030T3 (https=)
FR (1) FR2838444B1 (https=)
IL (1) IL164429A0 (https=)
MA (1) MA27191A1 (https=)
MX (1) MXPA04009841A (https=)
NZ (1) NZ536351A (https=)
RU (1) RU2326125C2 (https=)
SI (1) SI2314311T1 (https=)
TN (1) TNSN04200A1 (https=)
WO (1) WO2003084979A2 (https=)
ZA (1) ZA200408451B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7422743B2 (en) * 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
FR2859725B1 (fr) * 2003-09-16 2006-03-10 Neovacs Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
AU2005220156B2 (en) * 2004-02-27 2011-06-02 Vaxconsulting Peptides of IL1 beta and TNF alpha and method of treatment using same
NZ566971A (en) 2005-09-28 2011-06-30 Cytos Biotechnology Ag Vaccine containing a virus like particle linked with an interleukin-1 molecule
NZ592943A (en) * 2008-11-17 2012-09-28 Uinv Kobenhavns Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
EP2480251B1 (en) 2009-09-21 2025-12-03 Peptinov Carrier conjugates of il-23-peptides and their induced antibodies
WO2011143280A2 (en) 2010-05-11 2011-11-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
WO2013140785A1 (ja) * 2012-03-18 2013-09-26 国立大学法人九州大学 疾患サンプル分析装置、分析システム及び分析方法
US9376489B2 (en) 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules
US10576131B2 (en) * 2015-06-03 2020-03-03 Affiris Ag IL-23-p19 vaccines
EP3696547B1 (en) * 2017-10-13 2025-08-13 Nibec Co., Ltd. Grp78-derived peptide for identifying high-efficiency stem cells
EP3966230A1 (en) * 2019-05-10 2022-03-16 Bimyo GmbH Bnip3 peptides for treatment of reperfusion injury
EP4486389A1 (en) 2022-02-28 2025-01-08 Tridem Bioscience GmbH & Co KG A conjugate comprising at least a beta-glucan

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
DE3841761A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
ATE136906T1 (de) * 1989-12-20 1996-05-15 Schering Corp Antikörperantagonisten gegen humanes interleukin- 4
EP0521918A4 (en) * 1990-03-19 1993-05-05 Peptide Technology Ltd Anti-tumour peptides
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
US5494662A (en) * 1992-04-27 1996-02-27 Ono Pharmaceutical Co., Ltd. Stimulator for bone formation
AU4554493A (en) * 1992-07-07 1994-01-31 Eleanor N. Fish Interferon receptor binding peptides
US5770191A (en) * 1995-05-24 1998-06-23 University Of Florida Active C-terminal peptides of interferon--gamma and their use
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
JP2001511649A (ja) * 1997-02-07 2001-08-14 トーマス・ジェファーソン・ユニバーシティ サイトカインレセプターガンマ鎖のペプチド模倣物
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale
AU5201399A (en) * 1997-09-30 1999-10-18 Pharmacia & Upjohn Company Tnf-related death ligand
AU773029B2 (en) * 1999-02-08 2004-05-13 Medvet Science Pty. Ltd. Cytokine-binding domain
KR20010102556A (ko) * 1999-03-11 2001-11-15 추후제출 암 및 과증식성 장애의 치료 조성물 및 치료방법
US7129072B1 (en) * 1999-08-30 2006-10-31 New York University Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
US6420346B1 (en) * 2000-02-07 2002-07-16 Rappaport Family Institute For Research In The Medical Sciences Polynucleotides encoding MIP-1α, MCP-1, MIP-1β, Rantes and TNF-α, and methods for treating rheumatoid arthritis
WO2002044197A2 (en) * 2000-12-01 2002-06-06 Fish Eleanor N Cytokine receptor binding peptides
US20030166589A1 (en) * 2001-06-05 2003-09-04 Nathan Karin Method and pharmaceutical composition for the treatment of multiple sclerosis

Similar Documents

Publication Publication Date Title
JP2005530723A5 (https=)
JP2004501101A5 (https=)
Lehner Autoimmunity in oral diseases, with special reference to recurrent oral ulceration
JP2019513817A5 (https=)
JP2021100937A5 (https=)
WO2006059108A3 (en) ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
JP2021505540A5 (https=)
KR101155294B1 (ko) 면역특이적으로 ＢＬｙＳ에 결합하는 항체
HUP0303173A2 (hu) Csökkent immunogenitású, módosított anti-EGFR-ellenanyagok
WO2004064759A3 (en) Use of tryptanthrin compounds for immune potentiation
JP2005537234A5 (https=)
JP2005508338A5 (https=)
WO2003090686A3 (en) Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
HU220995B1 (hu) TNF-antagonisták alkalmazása megnövekedett interleukin-6 szérumszinttel járó szepszis kezelésére szolgáló gyógyszerkészítmény előállítására
JP2008501716A5 (https=)
JP2006516116A5 (https=)
JP2013534532A5 (https=)
JP2002535285A5 (https=)
US5859207A (en) Superantigen agonist and antagonist peptides
DE69734317D1 (de) Anti-tnf antikörper / tnf rezeptor und methotrexat zur behandlung von autoimmunkrankheiten
JP2003518507A5 (https=)
US20110182922A1 (en) Peptides of il1 beta and tnf alpha and method of treatment using same
JP2006508039A5 (https=)
ATE465753T1 (de) Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
JP2004537500A5 (https=)